MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Vitamin D Cuts Pancreatic Cancer Risk By Half

Back to pancreas Blogs list Cancer blog  


Subscribe To Pancreas RSS Feed  RSS content feed What is RSS feed?

Vitamin D Cuts Pancreatic Cancer Risk By Half

Vitamin D Cuts Pancreatic Cancer Risk By Half
Consumption of Vitamin D tablets was found to cut the risk of pancreas cancer nearly in half, as per a research studyled by scientists at Northwestern and Harvard universities.

The findings point to Vitamin D's potential to prevent the disease, and is one of the first known studies to use a large-scale epidemiological survey to examine the relationship between the nutrient and cancer of the pancreas. The study, led by Halcyon Skinner, Ph.D., of Northwestern, appears in the recent issue of Cancer Epidemiology Biomarkers & Prevention.

The study examined data from two large, long-term health surveys and observed that taking the U.S. Recommended Daily Allowance of Vitamin D (400 IU/day) reduced the risk of pancreas cancer by 43 percent. By comparison, those who consumed less than 150 IUs per day experienced a 22 percent reduced risk of cancer. Increased consumption of the vitamin beyond 400 IUs per day resulted in no significant increased benefit.

"Because there is no effective screening for pancreas cancer, identifying controllable risk factors for the disease is essential for developing strategies that can prevent cancer," said Skinner.

"Vitamin D has shown strong potential for preventing and treating prostate cancer, and areas with greater sunlight exposure have lower incidence and mortality for prostate, breast, and colon cancers, leading us to investigate a role for Vitamin D in pancreas cancer risk. Few studies have examined this association, and we did observe a reduced risk for pancreas cancer with higher intake of Vitamin D".

Skinner, currently in the Department of Population Health Sciences at the University of Wisconsin School of Medicine and Public Health, and colleagues analyzed data from two long-term studies of health and diet practices, conducted at Harvard University. They looked at data on 46,771 men aged 40 to 75 years who took part in the Health Professionals Follow-up Study, and 75,427 women aged 38 to 65 years who participated in the Nurses' Health Study. Between the two studies, they identified 365 cases of pancreas cancer. The surveys are considered valuable for their prospective design, following health trends instead of looking at purely historical information, high follow-up rates and the ability to enable scientists like Skinner to incorporate data from two independent studies.

Pancreas cancer is a rapidly fatal disease and the fourth-leading cause of death from cancer in the United States. This year, the American Cancer Society estimates that 32,000 new cases of cancer will be diagnosed. About the same number of people will die this year from the disease. It has no known cure, and surgical therapys are not often effective. Except for cigarette smoking, no environmental factors or dietary practices have been associated with the disease.

In addition to Vitamin D, the scientists also measured the association between pancreas cancer and the intakes of calcium and retinol (Vitamin A). Calcium and retinol intakes showed no association with pancreas cancer risk, eventhough retinol is an antagonist of Vitamin D's ability to influence mineral balances and bone integrity.

For that reason, further research is necessary to determine if Vitamin D ingestion from dietary sources, like eggs, liver and fatty fish or fortified dairy products, or through sun exposure might be preferable to multi-vitamin supplements, which contain retinol.

The potential benefits of vitamin D for pancreas cancer were only recently established by other laboratory studies. Normal and malignant pancreas tissue contain high levels of the enzyme that converts circulating 25-hydroxyvitamin D into 1,25-dihydroxyvitamin D, the vitamin's active form. Other studies have shown an anti-cell proliferation effect of 1,25-dihydroxyvitamin D, potentially inhibiting tumor cells.

"In concert with laboratory results suggesting anti-tumor effects of Vitamin D, our results point to a possible role for Vitamin D in the prevention and possible reduction in mortality of pancreas cancer. Since no other environmental or dietary factor showed this risk relationship, more study of Vitamin D's role is warranted," Skinner said.


Posted by: Sue    Source




Did you know?
Consumption of Vitamin D tablets was found to cut the risk of pancreas cancer nearly in half, as per a research studyled by scientists at Northwestern and Harvard universities. The findings point to Vitamin D's potential to prevent the disease, and is one of the first known studies to use a large-scale epidemiological survey to examine the relationship between the nutrient and cancer of the pancreas. The study, led by Halcyon Skinner, Ph.D., of Northwestern, appears in the recent issue of Cancer Epidemiology Biomarkers and Prevention.

Medicineworld.org: Vitamin D Cuts Pancreatic Cancer Risk By Half

Advances in pancreatic cancer treatment| Detailed information on pancreatic cancer| Pancreas cancer main| Major topics in pancreatic cancer| Overview of pancreatic cancer| Pancreatic cancer resources| More resources for pancreatic cancer| Resources 3 for pancreatic cancer| Resources4 for pancreatic cancer| Resources5 for pancreatic cancer| Resources6 for pancreatic cancer| Resources7 for pancreatic cancer| Resources8 for pancreatic cancer|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.